ERICA DORONDO: Open Payments
NPI 1154661452 · FORD CITY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 72 payments from 23 companies in 2025. Trend: 2023 $560 · 2024 $1,014 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $297 |
| ABBVIE INC. | 11 | $163 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $97 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Dexcom, Inc. | 3 | $61 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $58 |
| Exact Sciences Corporation | 3 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Abbott Laboratories | 2 | $47 |
Products named: Wegovy, JARDIANCE, QULIPTA, Dexcom G6 Transmitter, XIFAXAN, TRINTELLIX, TRELEGY ELLIPTA, Cologuard Collection Kit.
Industry payments across PA — which companies pay providers there.
